It is a synthetic peptide derived from a protective protein found naturally in gastric juice
Oral or troche dose: Determined at APRN intake based on your GI indication and treatment goal Troche format: Held sublingually for 60 to 90 seconds before swallowing for improved absorption Best use case: GI inflammation, IBS, gut lining repair, Crohns management, systemic anti-inflammatory support Not optimal for: Localized tendon, joint, or muscle injury where injection near the site is more targeted Injury vs Gut Protocol: See What Dosing Looks Like for Your Use Case BPC-157 dosage differs by indication
BPC-157 works in the body through proposed repair pathways that involve blood vessel growth, cell movement, inflammation control, and tissue-protective signaling, but most evidence comes from animal and laboratory studies rather than confirmed human trials
The ideal approach combines peptide support for tissue biology with rehabilitation for mechanical function
United States Pharmacopeia (USP) For Research Use Only (RUO)
While the peptide has been studied for decades and has shown promising results in animal research, there is currently insufficient clinical evidence to establish the peptide therapys safety and effectiveness in humans